bepridil has been researched along with CBS Deficiency in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halvorsen, B | 1 |
| Brude, I | 1 |
| Drevon, CA | 1 |
| Nysom, J | 1 |
| Ose, L | 1 |
| Christiansen, EN | 1 |
| Nenseter, MS | 1 |
1 other study available for bepridil and CBS Deficiency
| Article | Year |
|---|---|
Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein.
Topics: Adolescent; Adult; Amidines; Arteriosclerosis; Azo Compounds; Bepridil; Biphenyl Compounds; Child; C | 1996 |